Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Buzz on the Bullboards: New Rising Opportunities

There has been a lot of attention on the tech sector and the stocks working in that marketplace as of late. Despite market volatility, the tech-heavy Nasdaq has displayed much growth this year as it dug itself out of the COVID hole that had investors and the markets at large p...

DIAGNOS poised for parabolic move as first of new cardio AI Applications comes to market

DIAGNOS Inc. (TSX-V: ADK) (OTCQB: DGNOF) (Frankfurt: 4D4) is a Canadian-based healthcare software technology company that pioneered ' C omputer A ssisted R etinal A nalysis' (CARA), applying artificial intelligence to non-invasively test, identify, and classify patients a...

Buzz on the Bullboards: 2021 The Year of the Cannabis Comeback?

(TAAT CEO, Setti Coscarella. Image via TAAT Lifestyle & Wellness Ltd.) If you look at one set of market headlines around COVID-19, you would read about stimulus packages, vaccine rollouts, and a general lightening in sentiment … but if you look news outlets, you see...

Coupa Software Shares Rise 10% on Q2 Earnings

Enterprise cloud software firm Coupa Software's shares are trading 10% higher today after the company announced Q2/20 earnings and issued a cautious macroeconomic outlook for the rest of 2019. Business Spend Management software company Coupa Software Inc. (COUP:NASDA...

Buzz on the Bullboards: Tracking the Big Movers of 2020

(Image via Mind Medicine Inc.) To say 2020 was a challenging year is an understatement. From markets hitting unprecedented highs to the economic cratering in March due to the COVID-19 Coronavirus pandemic that put stocks across the board to the ultimat...

The New Age of Advertising

With my involvement at Heelo, I have learned a lot about the new advertising world. There has been and still is a huge transformation taking place to digital advertising. You have experience with this from Google and Facebook that along with YouTube see the most web traf...

ITM Power, Nikola, Royal Helium - why investors are buying in now

Hydrogen is an interesting energy storage medium for modern ground mobility. The decisive factor for environmental protection, however, is the way in which the energy source is obtained. Green hydrogen is produced from renewable energy sources, i.e. electricity is used for its...

Five Small Caps Expanding Their Business Amid the Covid-19 Pandemic

Some small caps are finding new opportunities during the Covid-19 pandemic. While the extreme market volatility over the past weeks creates a lot of uncertainly, some companies have seen business increase amid the Covid-19 epidemic. Here are a handful of sma...

Ardelyx's Shares Soar 65% as Tenapanor Phase 3 Study Hits the Mark

Clinical-stage specialized biopharmaceutical company Ardelyx announced positive results today for its phase 3 AMPLIFY study for tenapanor aimed at improving treatment for cardiorenal diseases. This morning clinical-stage biopharmaceutical developer of medicines for th...

Biogen Shares Rebound Strongly on Updated Phase 3 Alzheimer's Data and Q3 Earnings

Shares of Biogen Inc. opened nearly 39% higher today after the firm announced plans to submit a Biologics License Application to the FDA in early 2020 for its Alzheimer's drug aducanumab based on new analysis of larger datasets from two phase 3 studies. The company also anno...
1 2 3 4 5 6 7 8 9 10 ...